Veru

VERU

Biotechnology · Healthcare

Price

$2.38

+0.03 (+1.28%)

Market Cap

$38.2M

Exchange

NASDAQ Capital Market

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+74.8% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 8.4M (2021) → 14.6M (2025)

Veru Inc. is a small biotechnology company focused on developing drugs for cancer and serious infectious diseases. Its main drug candidates target prostate cancer and conditions like acute respiratory distress syndrome. The company sells a commercial product called ENTADFI, a combination pill for enlarged prostate, and has historically also sold a contraceptive product called FC2, a female condom distributed through public health programs.

Veru makes money through product sales and is working to generate revenue from new drug approvals. It operates primarily in the United States, with some international sales of FC2 through government and nonprofit health organizations. The company is small, with a market cap near zero and deeply negative returns on capital, which signals it is spending heavily while generating little profit. The biggest risk Veru faces is running out of cash before its pipeline drugs can complete clinical trials and reach the market.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

+75.9% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$16M/ year

↑ Rising (+22% vs prior year)

R&D investment increasing — building for the future

Insider Activity

12.8%ownership

Insiders own a meaningful stake in the company

Cash Runway

~10 months

$31M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Short runway — potential dilution ahead through share issuance

Cash watch

Veru has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

Data not available

Operating Margin

N/A

Data not available

ROCE

-20.8%

Weak — -20.8% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

-100.0%

Shrinking sales (-100.0% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial